NCT06245824 Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial Status NOT_YET_RECRUITING Phase PHASE4
NCT06242470 A Study of MGC026 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06240195 Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study Status RECRUITING Phase N/A
NCT06239467 First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer Status RECRUITING Phase PHASE1
NCT06239194 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06238921 Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT06238453 The Effect of Training Given by Whatsapp Application on Mamography Health Beliefs and Behaviors Status NOT_YET_RECRUITING Phase N/A
NCT06236373 The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia Status RECRUITING Phase N/A
NCT06234488 Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06233383 Developing Screening Clinical Breast Examination Implementation Strategies in South Africa Status COMPLETED Phase N/A
NCT06232070 Real World Evaluation of Lunit INSIGHT MMG Technology Status NOT_YET_RECRUITING Phase N/A
NCT06231693 Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil Status TERMINATED Phase N/A
NCT06229392 A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer Status WITHDRAWN Phase PHASE1
NCT06229067 Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06228768 Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer Status COMPLETED Phase NA
NCT06227728 Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. Status RECRUITING Phase N/A
NCT06227338 ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study Status RECRUITING Phase NA
NCT06227117 Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer Status RECRUITING Phase PHASE2